In this latter cohort, those with upregulated ABAT transcripts (n = 5) had a lower likelihood of developing new neoplasms following initial therapy, relative to unaltered (n = 28) (chi-squared test; p = 2.6 × 10−3). The gene discussed is ABAT; the disease is neoplasm.